Active, not recruitingPhase 3NCT03671148
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)
Studying NON RARE IN EUROPE: Psoriatic arthritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- AbbVie
- Principal Investigator
- ABBVIE INC.AbbVie
- Intervention
- Placebo(biological)
- Enrollment
- 444 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2020
Study locations (20)
- Pinnacle Research Group /ID# 167953, Anniston, Alabama, United States
- St. Jude Heritage /ID# 166842, Fullerton, California, United States
- Newport Huntington Medica /ID# 207423, Huntington Beach, California, United States
- Arthritis & Osteo Medical Ctr /ID# 166541, La Palma, California, United States
- East Bay Rheumatology Medical /ID# 166845, San Leandro, California, United States
- Inland Rheum Clin Trials Inc. /ID# 166621, Upland, California, United States
- Denver Arthritis Clinic /ID# 166442, Denver, Colorado, United States
- New England Research Associates, LLC /ID# 166525, Bridgeport, Connecticut, United States
- Yale University /ID# 166330, New Haven, Connecticut, United States
- Arthritis & Rheumatic Disease Specialties /ID# 212582, Aventura, Florida, United States
- SIMED Health, LLC /ID# 207457, Gainesville, Florida, United States
- Sweet Hope Research Specialty Inc /ID# 168163, Hialeah, Florida, United States
- Rheum Assoc of Central FL /ID# 201629, Orlando, Florida, United States
- HMD Research LLC /ID# 208428, Orlando, Florida, United States
- Millennium Research /ID# 201627, Ormond Beach, Florida, United States
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03671148 on ClinicalTrials.govOther trials for NON RARE IN EUROPE: Psoriatic arthritis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07290036A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsUCB Biopharma SRL
- RECRUITINGNANCT06382051Modifying PEST for Psoriatic Arthritis ScreeningNovartis Pharmaceuticals
- RECRUITINGPHASE2NCT06176508Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic ArthritisHansoh BioMedical R&D Company
- ENROLLING BY INVITATIONNANCT06176586Mat Pilates Exercise Program in Patients With Axial Psoriatic ArthritisIzmir Katip Celebi University
- RECRUITINGNCT06437392Evaluation of Sarcopenia and Related Factors in Patients Diagnosed With Psoriatic ArthritisAnkara City Hospital Bilkent
- RECRUITINGNCT07277491Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease ActivityCairo University
- ACTIVE NOT RECRUITINGPHASE3NCT04908189A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor TreatmentBristol-Myers Squibb
- RECRUITINGNCT03768271APACHE Cohort (A Psoriatic Arthritis CoHort)Assistance Publique - Hôpitaux de Paris
See all trials for NON RARE IN EUROPE: Psoriatic arthritis →